Ovid Therapeutics

New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

$60.0M raised

Mar 2026

Post-IPO Equity

Biopharma Biotechnology Health Care

Top Investors

RA Capital Management Balyasny Asset Management Cormorant Asset Management Janus Henderson Investors Redmile Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ovid Therapeutics

How much funding has Ovid Therapeutics raised?

Ovid Therapeutics has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Ovid Therapeutics's investors?

Ovid Therapeutics's investors include RA Capital Management, Balyasny Asset Management, Cormorant Asset Management, Janus Henderson Investors, Redmile Group.

Where is Ovid Therapeutics headquartered?

Ovid Therapeutics is headquartered in New York, United States.

What does Ovid Therapeutics do?

Ovid Therapeutic's purpose is to solve intractable medical problems.

What stage is Ovid Therapeutics at?

Ovid Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2026.

MLA

"Ovid Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/ovid-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2026). Ovid Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/ovid-therapeutics

Wikipedia (cite web)

{{cite web |title=Ovid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ovid-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2026.